5-136029105-G-C

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_000358.3(TGFBI):​c.50G>C​(p.Gly17Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,525,908 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00071 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000066 ( 0 hom. )

Consequence

TGFBI
NM_000358.3 missense

Scores

1
2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1B:1

Conservation

PhyloP100: 0.552

Publications

0 publications found
Variant links:
Genes affected
TGFBI (HGNC:11771): (transforming growth factor beta induced) This gene encodes an RGD-containing protein that binds to type I, II and IV collagens. The RGD motif is found in many extracellular matrix proteins modulating cell adhesion and serves as a ligand recognition sequence for several integrins. This protein plays a role in cell-collagen interactions and may be involved in endochondrial bone formation in cartilage. The protein is induced by transforming growth factor-beta and acts to inhibit cell adhesion. Mutations in this gene are associated with multiple types of corneal dystrophy. [provided by RefSeq, Jul 2008]
TGFBI Gene-Disease associations (from GenCC):
  • epithelial-stromal TGFBI dystrophy
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • granular corneal dystrophy type I
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • granular corneal dystrophy type II
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • lattice corneal dystrophy type I
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • Reis-Bucklers corneal dystrophy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • Thiel-Behnke corneal dystrophy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • epithelial basement membrane dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.022079647).
BS2
High AC in GnomAd4 at 108 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGFBINM_000358.3 linkc.50G>C p.Gly17Ala missense_variant Exon 1 of 17 ENST00000442011.7 NP_000349.1 Q15582A0A0S2Z4Q2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGFBIENST00000442011.7 linkc.50G>C p.Gly17Ala missense_variant Exon 1 of 17 1 NM_000358.3 ENSP00000416330.2 Q15582
TGFBIENST00000504185.5 linkn.118G>C non_coding_transcript_exon_variant Exon 1 of 5 4
TGFBIENST00000506699.5 linkn.115G>C non_coding_transcript_exon_variant Exon 1 of 17 2
TGFBIENST00000507018.5 linkn.-35G>C upstream_gene_variant 5 ENSP00000421540.1 H0Y8M8

Frequencies

GnomAD3 genomes
AF:
0.000710
AC:
108
AN:
152134
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00253
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000912
AC:
11
AN:
120578
AF XY:
0.0000150
show subpopulations
Gnomad AFR exome
AF:
0.00229
Gnomad AMR exome
AF:
0.0000841
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000662
AC:
91
AN:
1373658
Hom.:
0
Cov.:
31
AF XY:
0.0000443
AC XY:
30
AN XY:
677928
show subpopulations
African (AFR)
AF:
0.00270
AC:
80
AN:
29660
American (AMR)
AF:
0.0000851
AC:
3
AN:
35234
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24778
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34610
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78236
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34062
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4074
European-Non Finnish (NFE)
AF:
9.30e-7
AC:
1
AN:
1075578
Other (OTH)
AF:
0.000122
AC:
7
AN:
57426
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000709
AC:
108
AN:
152250
Hom.:
1
Cov.:
32
AF XY:
0.000645
AC XY:
48
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.00253
AC:
105
AN:
41580
American (AMR)
AF:
0.000131
AC:
2
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5140
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67982
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000925
Hom.:
0
Bravo
AF:
0.000876
ExAC
AF:
0.0000924
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Aug 13, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.50G>C (p.G17A) alteration is located in exon 1 (coding exon 1) of the TGFBI gene. This alteration results from a G to C substitution at nucleotide position 50, causing the glycine (G) at amino acid position 17 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

TGFBI-related disorder Benign:1
Jul 31, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
18
DANN
Benign
0.58
DEOGEN2
Benign
0.22
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.59
D
LIST_S2
Benign
0.48
T
M_CAP
Uncertain
0.24
D
MetaRNN
Benign
0.022
T
MetaSVM
Benign
-0.65
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.55
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
0.47
N
REVEL
Uncertain
0.32
Sift
Benign
0.51
T
Sift4G
Benign
0.51
T
Polyphen
0.0010
B
Vest4
0.22
MVP
0.73
MPC
0.24
ClinPred
0.0023
T
GERP RS
0.73
PromoterAI
-0.077
Neutral
Varity_R
0.037
gMVP
0.31
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs770699457; hg19: chr5-135364794; API